Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Plos One|October 8, 2013
Differential binding of IgG and IgA to mucus of the female reproductive tractKelly M Fahrbach, Olga Malykhina, Daniel J Stieh, et al.
Retrovirology|September 25, 2015
Discrete partitioning of HIV-1 Env forms revealed by viral captureDaniel J Stieh, Deborah F King, Katja Klein, et al.
Vaccine|August 9, 2024
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease riskSanne Roels, Matthias Bruckner, Jerald Sadoff, et al.
Cell Host & Microbe|April 15, 2016
Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in MacaquesDaniel J Stieh, Edgar Matias, Huanbin Xu, et al.
Retrovirology|March 22, 2013
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoproteinDaniel J Stieh, Joshua L Phillips, Paul M Rogers, et al.
Plos Pathogens|October 10, 2014
Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tractDaniel J Stieh, Danijela Maric, Z L Kelley, et al.
AIDS (London, England)|January 26, 2017
Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factorsChristel Chehoud, Daniel J Stieh, Aubrey G Bailey, et al.
Microbiology Spectrum|May 24, 2023
Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced SeroreactivityOle Lagatie, Dax Lauwers, Harvinder Singh, et al.
NPJ Vaccines|May 21, 2026
The role of naturally occurring and vaccine-induced Ad26 neutralizing antibodies in immunogenicity of Ad26-based vaccinesMariska G M van Rosmalen, Joris Menten, Daniel J Stieh, et al.
Msystems|January 15, 2026
Associations between the microbiome and immune responses to an adenovirus-based HIV-1 candidate vaccine are distinct between African and US cohortsYuhao Li, Daniel J Stieh, Lindsay Droit, et al.
Pageof 4